 |
Iboctadekin |
|---|---|
| Trade Name | |
| Orphan Indication | Renal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2005-06-03 00:00:00 |
| Sponsor | GlaxoSmithKline LLC;Corporation service Company, Suite 400;Wilmington, Delaware, 19808 |
| |
Iboctadekin |
|---|---|
| Trade Name | |
| Orphan Indication | Renal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2005-06-03 00:00:00 |
| Sponsor | GlaxoSmithKline LLC;Corporation service Company, Suite 400;Wilmington, Delaware, 19808 |